Brief: AOP Health International Says Offer For Shield Therapeutics Has Lapsed
15/06/2023 18:25
June 15 (Reuters) - AOP Health International:
* AOP HEALTH INTNL. SHIELD THERAPEUTICS - LAPSE OF OFFER
* AOP HEALTH INTERNATIONAL ON SHEILD THERAPEUTICS SAYS,
ACCEPTANCE
CONDITION NOT BEEN SATISFIED, MANDATORY OFFER LAPSED & OFFER
PERIOD HAS NOW ENDED
Source text for Eikon: ID:nRSO8985Ca
Further company coverage: STXS.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update